Difficulty: Medium
Average Score: 74%
Practice
A 78-year-old man has an emergency partial colectomy for lower gastrointestinal bleeding. A localized colonic adenocarcinoma is completely resected. The surgeon did not dissect lymph nodes for metastatic sampling. The patient wants to know if he should have chemotherapy. Should he?
Correct answer
B
Rationale
The correct answer is B) No because he can be followed with serial carcinoembryonic antigens and CT scans. In this scenario, the patient had a localized colonic adenocarcinoma completely resected without lymph node dissection. Given his age and the absence of lymph node involvement, adjuvant chemotherapy may not be necessary. Instead, close monitoring through serial carcinoembryonic antigen tests and CT scans can be used to detect any recurrence or metastasis early.
Option A is incorrect because administering chemotherapy without knowing the complete staging and without clear indication may expose the patient to unnecessary risks and side effects. Option C is incorrect as the presence of severe bleeding does not necessarily indicate advanced disease, especially when the tumor has been completely resected. Option D is incorrect as age alone should not be the sole determinant of treatment decisions, and assuming the patient will not have any problems during his lifetime is not evidence-based.
In an educational context, this question highlights the importance of individualized treatment decisions in oncology, considering factors such as tumor characteristics, staging, patient preferences, and risk-benefit analysis. It underscores the significance of regular monitoring and surveillance in cancer care to ensure early detection of any recurrence or progression.
Option A is incorrect because administering chemotherapy without knowing the complete staging and without clear indication may expose the patient to unnecessary risks and side effects. Option C is incorrect as the presence of severe bleeding does not necessarily indicate advanced disease, especially when the tumor has been completely resected. Option D is incorrect as age alone should not be the sole determinant of treatment decisions, and assuming the patient will not have any problems during his lifetime is not evidence-based.
In an educational context, this question highlights the importance of individualized treatment decisions in oncology, considering factors such as tumor characteristics, staging, patient preferences, and risk-benefit analysis. It underscores the significance of regular monitoring and surveillance in cancer care to ensure early detection of any recurrence or progression.